Markets
Will the new dual-drug strategy for triple-negative breast cancer show a significant improvement in patient outcomes by March 2027?
Yes0%No0%
Loading...
About this market
This market resolves to Yes if peer-reviewed study results published by March 2027 show that the dual-drug strategy significantly improves clinical outcomes (such as progression-free survival or overall response rate) for patients with triple-negative breast cancer compared to current standard treatments.
Rules
- Market closes at 3/31/2027.
- Logic weighted resolution applies.
Other open markets in Health
Will the proposed combination of Atrium and WakeMed be approved by February 2027?
This market resolves to Yes if the proposed combination of healthcare providers Atrium and WakeMed receives approval from the relevant regulatory authorities by February 2027. The approval must be publicly confirmed by that date.
Will the US National Institutes of Health introduce new guidelines for exercise in older adults by December 31, 2026?
This market resolves to Yes if the US National Institutes of Health (NIH) publicly announces new guidelines specifically aimed at exercise for adults aged 65 and older by December 31, 2026. The announcement must be reported by a credible health or governmental news source.
Will the partnership between NCQA and Komodo Health AI result in new quality measures being officially implemented by February 2027?
This market resolves to Yes if the National Committee for Quality Assurance (NCQA) officially implements new quality measures developed in partnership with Komodo Health AI by February 28, 2027. The implementation must be publicly announced by NCQA or verifiable through reliable healthcare industry news sources.
Will Medicaid enrollment in Illinois decrease by more than 10% by the end of 2027?
This market resolves to Yes if Medicaid enrollment in Illinois, as reported by the Illinois Department of Healthcare and Family Services, decreases by more than 10% from its current figures by December 31, 2027.
Will a wearable smart patch for automatic fentanyl overdose aid be approved by the FDA by December 31, 2026?
This market resolves to Yes if a wearable smart patch designed to automatically deliver aid during a fentanyl overdose receives FDA approval by December 31, 2026. If the FDA does not approve such a device by this date, it resolves to No.
Will the NIH implement the proposed changes to its grant review process by February 2027?
This market resolves to Yes if the National Institutes of Health (NIH) officially implements the proposed changes to their grant review process, as described in recent news, by February 28, 2027. The changes involve moving away from transparent numerical scores to a few broad categories like 'Most competitive', 'Competitive', and 'Not discussed'.